Management of refractory ascites and hepatorenal syndrome
- PMID: 21080246
- DOI: 10.1007/s11894-010-0156-6
Management of refractory ascites and hepatorenal syndrome
Abstract
One of the most common manifestations of the development of portal hypertension in the patient with cirrhosis is the appearance of ascites. Once ascites develops, the prognosis worsens and the patient becomes susceptible to complications such as bacterial peritonitis, hepatic hydrothorax, hyponatremia, and complications of diuretic therapy. As the liver disease progresses, the ascites becomes more difficult to treat and many patients develop renal failure. Most patients can be managed by diuretics which, when used correctly, will control the ascites. Spontaneous bacterial peritonitis can be treated effectively, but portends a worse prognosis. Once the ascites becomes refractory to diuretics, liver transplantation is the best option, although use of transjugular intrahepatic portosystemic shunts will control the ascites in many patients. Lastly, the development of hepatorenal syndrome indicates the patient's liver disease is advanced, and transplantation again is the best option. However, use of vasoconstrictors may improve renal function in some patients, helping in their management while they await a liver transplant.
Similar articles
-
Management of ascites and hepatorenal syndrome.Hepatol Int. 2018 Feb;12(Suppl 1):122-134. doi: 10.1007/s12072-017-9815-0. Epub 2017 Aug 23. Hepatol Int. 2018. PMID: 28836115 Review.
-
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1. J Hepatol. 2010. PMID: 20633946 Review. No abstract available.
-
Ascites and Hepatorenal Syndrome.Clin Liver Dis. 2019 Nov;23(4):659-682. doi: 10.1016/j.cld.2019.06.002. Epub 2019 Aug 7. Clin Liver Dis. 2019. PMID: 31563217 Review.
-
Hepatorenal syndrome.Trop Gastroenterol. 2002 Jul-Sep;23(3):113-6. Trop Gastroenterol. 2002. PMID: 12693150 Review.
-
Management of cirrhosis and ascites.N Engl J Med. 2004 Apr 15;350(16):1646-54. doi: 10.1056/NEJMra035021. N Engl J Med. 2004. PMID: 15084697 Review. No abstract available.
Cited by
-
Refractory ascites-the contemporary view on pathogenesis and therapy.PeerJ. 2019 Oct 15;7:e7855. doi: 10.7717/peerj.7855. eCollection 2019. PeerJ. 2019. PMID: 31637125 Free PMC article.
-
Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome.Arch Med Sci. 2012 Jul 4;8(3):555-62. doi: 10.5114/aoms.2012.29281. Arch Med Sci. 2012. PMID: 22852015 Free PMC article.
-
Effect of nitric oxide pathway regulation on water/sodium balance and renal function in a rodent model of acute liver and renal failure.Med Sci Monit. 2014 Sep 27;20:1735-44. doi: 10.12659/MSM.890757. Med Sci Monit. 2014. PMID: 25270512 Free PMC article.
-
Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation.Dig Dis Sci. 2013 Nov;58(11):3103-11. doi: 10.1007/s10620-013-2791-x. Epub 2013 Aug 4. Dig Dis Sci. 2013. PMID: 23912247 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials